XML 17 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenue $ 443.7 $ 414.9 $ 875.4 $ 799.8
Cost of revenue 238.5 230.4 470.8 438.9
Gross profit 205.2 184.5 404.6 360.9
Operating expenses:        
Selling, general and administrative 110.6 102.5 220.9 200.6
Research and development 43.6 40.3 86.8 77.9
Other charges, net 2.2 6.4 10.0 9.5
Total operating expenses 156.4 149.2 317.7 288.0
Operating income 48.8 35.3 86.9 72.9
Interest and other income (expense), net (5.5) (5.1) (7.8) (11.1)
Income before income taxes and noncontrolling interest in consolidated subsidiaries 43.3 30.2 79.1 61.8
Income tax provision 11.8 6.2 20.2 16.1
Consolidated net income 31.5 24.0 58.9 45.7
Net income attributable to noncontrolling interest in consolidated subsidiaries 0.3 0.6 0.7 0.7
Net income attributable to Bruker Corporation $ 31.2 $ 23.4 $ 58.2 $ 45.0
Net income per common share attributable to Bruker Corporation shareholders:        
Basic (in dollars per share) $ 0.20 $ 0.15 $ 0.37 $ 0.28
Diluted (in dollars per share) $ 0.20 $ 0.15 $ 0.37 $ 0.28
Weighted average common shares outstanding:        
Basic (in shares) 156.1 159.5 156.0 159.6
Diluted (in shares) 157.0 160.4 157.0 160.4
Comprehensive income (loss) $ (5.4) $ 71.6 $ 46.4 $ 109.1
Less: Comprehensive income (loss) attributable to noncontrolling interests (0.2) 1.0 0.4 1.2
Comprehensive income (loss) attributable to Bruker Corporation $ (5.2) $ 70.6 $ 46.0 $ 107.9
Dividend declared per common share (in dollars per share) $ 0.04 $ 0.04 $ 0.08 $ 0.08
Product        
Revenue $ 368.1 $ 345.9 $ 720.3 $ 664.8
Cost of revenue 188.7 191.5 374.3 364.2
Service        
Revenue 73.5 67.1 151.2 130.4
Cost of revenue 49.1 38.7 95.6 74.4
Other        
Revenue 2.1 1.9 3.9 4.6
Cost of revenue $ 0.7 $ 0.2 $ 0.9 $ 0.3